{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T11:11:48.550702+00:00","published_at":"2026-10-17T04:46:55.096783+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1lhrjfns4y0kb","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:brigitte-lindsay","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:6a3981c365f4fda28dd62286c91313e11168ba67c661627a6227095f352e9a7b"],"summary":"Brigitte Lindsay executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18sn5af14k47qn","event_type":"CFO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:james-levine","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:fe568caa6f8b88aeb5182083f99e150b1550df326710fcd5980dc9070e266649"],"summary":"James Levine executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1goqyxe1aw4c9a","event_type":"CFO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:joshua-muntner","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:2c82905a2e13a37721d8ec8217b850d32f6c6c6a71073058632ab5f9fa4174d6"],"summary":"Joshua Muntner executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yq1041174vtgp","event_type":"CEO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:mani-mohindru-ph-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:9cf11a2356936a3ab9babc6e856d5d4221b249404f05ef4a64f514c15177590f"],"summary":"Mani Mohindru, Ph.D. executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1912cky1polluu","event_type":"CEO_CHANGED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:mark-erlander-ph-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:1e152fa40916b305fcdda3e58b4d2159b21aaf33929a10f37644c62c452c9eeb"],"summary":"Mark Erlander, Ph.D. executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1f44128jy00v4","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:roger-sidhu-md-frcpc","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:a91b47d45e7b01e29f812847dc2e396a3dc32cad2035f17b34abe8cbbee343f2"],"summary":"Roger Sidhu MD, FRCPC executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fmhn6b15dpfeb","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:tod-smeal-ph-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:48bacd197f448d60d89e6007334a40ece9afab477cc51c7db3179dc455786c79"],"summary":"Tod Smeal, Ph.D. executive of Cardiff Oncology, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2wc95y1lgdqtm","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:mani-mohindru-ph-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Mani Mohindru, Ph.D. seat on Cardiff Oncology, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:19h68wb1wfes6p","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:renee-p-tannenbaum-pharm-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Renee P. Tannenbaum, Pharm.D. seat on Cardiff Oncology, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jytskl1l8tsnt","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:gary-w-pace-ph-d","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Gary W. Pace, Ph.D. seat on Cardiff Oncology, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vftzeuc4hepu","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:lle-white","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Lle White seat on Cardiff Oncology, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1acirtc1stjr0u","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:committee:cardiff-oncology-inc:audit-chair-compensation","alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Audit · Chair; Compensation committee of Cardiff Oncology, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pb1r861ouxnfo","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:55.096783+00:00","subject_ids":["alpha:person:lle-white","alpha:committee:cardiff-oncology-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586"],"summary":"Lle White member of Audit · Chair; Compensation, effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:5","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gary-w-pace-ph-d","object_label":"Gary W. Pace, Ph.D.","object_source_name_forms":[],"value":"Gary W. Pace, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gary-w-pace-ph-d","name":"Gary W. Pace, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cardiff Oncology, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:19:01.21+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:6","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lle-white","object_label":"Lle White","object_source_name_forms":[],"value":"Lle White: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lle-white","name":"Lle White"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cardiff Oncology, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:19:01.21+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:7","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mani-mohindru-ph-d","object_label":"Mani Mohindru, Ph.D.","object_source_name_forms":[],"value":"Mani Mohindru, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mani-mohindru-ph-d","name":"Mani Mohindru, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cardiff Oncology, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:19:01.21+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:8","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:renee-p-tannenbaum-pharm-d","object_label":"Renee P. Tannenbaum, Pharm.D.","object_source_name_forms":[],"value":"Renee P. Tannenbaum, Pharm.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:renee-p-tannenbaum-pharm-d","name":"Renee P. Tannenbaum, Pharm.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cardiff Oncology, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:19:01.21+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:9","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brigitte-lindsay","object_label":"Brigitte Lindsay","object_source_name_forms":[],"value":"Brigitte Lindsay: Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brigitte-lindsay","name":"Brigitte Lindsay"},"title":"Chief Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:6a3981c365f4fda28dd62286c91313e11168ba67c661627a6227095f352e9a7b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:30.111447+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:10","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:james-levine","object_label":"James Levine","object_source_name_forms":[],"value":"James Levine: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:james-levine","name":"James Levine"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:fe568caa6f8b88aeb5182083f99e150b1550df326710fcd5980dc9070e266649","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:32.68712+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:11","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:joshua-muntner","object_label":"Joshua Muntner","object_source_name_forms":[],"value":"Joshua Muntner: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:joshua-muntner","name":"Joshua Muntner"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:2c82905a2e13a37721d8ec8217b850d32f6c6c6a71073058632ab5f9fa4174d6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:30.60022+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:12","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mani-mohindru-ph-d","object_label":"Mani Mohindru, Ph.D.","object_source_name_forms":[],"value":"Mani Mohindru, Ph.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mani-mohindru-ph-d","name":"Mani Mohindru, Ph.D."},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:9cf11a2356936a3ab9babc6e856d5d4221b249404f05ef4a64f514c15177590f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:29.583734+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:13","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-erlander-ph-d","object_label":"Mark Erlander, Ph.D.","object_source_name_forms":[],"value":"Mark Erlander, Ph.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-erlander-ph-d","name":"Mark Erlander, Ph.D."},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:1e152fa40916b305fcdda3e58b4d2159b21aaf33929a10f37644c62c452c9eeb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:32.068013+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:14","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:roger-sidhu-md-frcpc","object_label":"Roger Sidhu MD, FRCPC","object_source_name_forms":[],"value":"Roger Sidhu MD, FRCPC: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:roger-sidhu-md-frcpc","name":"Roger Sidhu MD, FRCPC"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:a91b47d45e7b01e29f812847dc2e396a3dc32cad2035f17b34abe8cbbee343f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:31.111892+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010:leadership_role:15","subject_id":"alpha:company:e3ed8b22-cdcd-4f8b-b883-5c95b0c7b010","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:tod-smeal-ph-d","object_label":"Tod Smeal, Ph.D.","object_source_name_forms":[],"value":"Tod Smeal, Ph.D.: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:tod-smeal-ph-d","name":"Tod Smeal, Ph.D."},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:48bacd197f448d60d89e6007334a40ece9afab477cc51c7db3179dc455786c79","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:31.604368+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:17165f15f85d87e7856e6b28bdd7b31bf667fd25214975766e7d6cbc0dfc0586","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cardiff Oncology, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T23:19:01.21+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:6a3981c365f4fda28dd62286c91313e11168ba67c661627a6227095f352e9a7b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:30.111447+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fe568caa6f8b88aeb5182083f99e150b1550df326710fcd5980dc9070e266649","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:32.68712+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2c82905a2e13a37721d8ec8217b850d32f6c6c6a71073058632ab5f9fa4174d6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:30.60022+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9cf11a2356936a3ab9babc6e856d5d4221b249404f05ef4a64f514c15177590f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:29.583734+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1e152fa40916b305fcdda3e58b4d2159b21aaf33929a10f37644c62c452c9eeb","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:32.068013+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a91b47d45e7b01e29f812847dc2e396a3dc32cad2035f17b34abe8cbbee343f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:31.111892+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:48bacd197f448d60d89e6007334a40ece9afab477cc51c7db3179dc455786c79","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CRDF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-16T01:01:31.604368+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.847,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.846},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:55.096783+00:00","observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":"2026-10-17T04:46:55.096783+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cardiff-oncology-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cardiff-oncology-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}